LEADER 02400oam  22006134a 450 
001 9910695711103321
005 20070430092057.0
035   $a(CKB)5470000002372674
035   $a(OCoLC)50244317
035   $a(EXLCZ)995470000002372674
100   $a20020712d2002      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aManagement of hepatitis C$b[electronic resource] $e2002 : January 1997 through April 2002 : 4,841 citations /$fprepared by Kristine M. Scannell, Carolyn C. Willard, Leonard B. Seeff
210  1$aBethesda, Md. (8600 Rockville Pike) :$cU.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section,$d[2002]
215   $avi, 280 pages $cdigital, PDF file
225 1 $aCurrent bibliographies in medicine ;$v2002-3
300   $aTitle from title screen (viewed July 12, 2002).
300   $a"2002 June."
300   $aIn support of the Second NIH Consensus Development Conference on Hepatitis C, held June 10-12, 2002, at NIH, Bethesda, Md.
517   $aManagement of hepatitis C 
606   $aHepatitis C$vBibliography
606   $aHepatitis C$xTreatment$vBibliography
606   $aHepatitis C virus$vBibliography
606   $aHepatitis C$xdiagnosis
606   $aHepatitis C$xdrug therapy
606   $aHepatitis C$xepidemiology
606   $aHepacivirus
606   $aInterferon-alpha$xtherapeutic use
608   $aBibliography.
608   $aBibliographies.$2lcgft
615  0$aHepatitis C
615  0$aHepatitis C$xTreatment
615  0$aHepatitis C virus
615 12$aHepatitis C$xdiagnosis.
615 12$aHepatitis C$xdrug therapy.
615 12$aHepatitis C$xepidemiology.
615 22$aHepacivirus.
615 22$aInterferon-alpha$xtherapeutic use.
700   $aScannell$b Kristine$01382766
701   $aWillard$b Carolyn$01401656
701   $aSeeff$b Leonard B$01410756
712 02$aNational Library of Medicine (U.S.).$bReference Section.
712 12$aNational Institutes of Health Consensus Development Conference on Management of Hepatitis C.
801  0$bNLM
801  1$bNLM
801  2$bGPO
906   $aBOOK
912   $a9910695711103321
996   $aManagement of hepatitis C$93500138
997   $aUNINA